Related references
Note: Only part of the references are listed.Multiple early factors anticipate post-acute COVID-19 sequelae
Yapeng Su et al.
CELL (2022)
Why All the Fury over Furin?
Essam Eldin A. Osman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
CELL METABOLISM (2021)
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
Bryan A. Johnson et al.
NATURE (2021)
Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin
Tiffany Tang et al.
ACS INFECTIOUS DISEASES (2021)
Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: Updates, challenges and perspectives
Matthew J. McNulty et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Design and Structure-Activity Relationship of a Potent Furin Inhibitor Derived from Influenza Hemagglutinin
Monika A. Lewandowska-Goch et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin
Thuy Van Lam van et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Lukas Wettstein et al.
NATURE COMMUNICATIONS (2021)
Therapeutic benefits of recombinant alpha1-antitrypsin IgG1 Fc-fusion protein in experimental emphysema
Katsuyuki Takeda et al.
RESPIRATORY RESEARCH (2021)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Markus Hoffmann et al.
MOLECULAR CELL (2020)
Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancer
Zongsheng He et al.
CANCER LETTERS (2020)
TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
Dorothea Bestle et al.
LIFE SCIENCE ALLIANCE (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Ludovico Cantuti-Castelvetri et al.
SCIENCE (2020)
Inhibition of Furin-mediated Processing Results in Suppression of Astrocytoma Cell Growth and Invasiveness (vol 8, pg 1740, 2002)
Javier Mercapide et al.
CLINICAL CANCER RESEARCH (2019)
FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice
Gopala K. Yakala et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
POMC: THE PHYSIOLOGICAL POWER OF HORMONE PROCESSING
Erika Harno et al.
PHYSIOLOGICAL REVIEWS (2018)
The proprotein convertase furin in tumour progression
Patricia Jaaks et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Proprotein convertase furin/PCSK3 and atherosclerosis: New insights and potential therapeutic targets
Kun Ren et al.
ATHEROSCLEROSIS (2017)
Elongated and Shortened Peptidomimetic Inhibitors of the Proprotein Convertase Furin
Kornelia Hardes et al.
CHEMMEDCHEM (2017)
Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease
Sujoy Ghosh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays
Bruno Ramos-Molina et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Therapeutic uses of furin and its inhibitors: a patent review
Frederic Couture et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Effect of Furin inhibitor on lung adenocarcinoma cell growth and metastasis
Yong-Chao Ma et al.
CANCER CELL INTERNATIONAL (2014)
Optimization of Furin Inhibitors To Protect against the Activation of Influenza Hemagglutinin H5 and Shiga Toxin
Hugo Gagnon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Large-scale association analysis identifies new risk loci for coronary artery disease
Panos Deloukas et al.
NATURE GENETICS (2013)
Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases
Gero L. Becker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Hypoxia enhances cancer cell invasion through relocalization of the proprotein convertase furin from the trans-golgi network to the cell surface
Dominique Arsenault et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
The biology and therapeutic targeting of the proprotein convertases
Nabil G. Seidah et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
FurinDB: A Database of 20-Residue Furin Cleavage Site Motifs, Substrates and Their Associated Drugs
Sun Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Landmarks in Insulin Research
Colin W. Ward et al.
Frontiers in Endocrinology (2011)
Selective and potent furin inhibitors protect cells from anthrax without significant toxicity
Albert G. Remacle et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
Potent Inhibitors of Furin and Furin-like Proprotein Convertases Containing Decarboxylated P1 Arginine Mimetics
Gero L. Becker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules
Tomoko Komiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells
Nathalie Scamuffa et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The tissue-specific processing of pro-opiomelanocortin
A. B. Bicknell
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide
Berend Jan Bosch et al.
JOURNAL OF VIROLOGY (2008)
Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine
Guan-Sheng Jiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Shape-shifting serpins - advantages of a mobile mechanism
James A. Huntington
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Identification of a pH sensor in the furin propeptide that regulates enzyme activation
Sylvain F. Feliciangeli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1 - Impact on the bioactivation of proproteins
S McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of furin by polyarginine-containing peptides - Nanomolar inhibition by NONA-D-arginine
MM Kacprzak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo
MS Sarac et al.
INFECTION AND IMMUNITY (2004)
The crystal structure of the proprotein processing proteinase furin explains its stringent specificity
S Henrich et al.
NATURE STRUCTURAL BIOLOGY (2003)
Irreversible inhibitors of serine, cysteine, and threonine proteases
JC Powers et al.
CHEMICAL REVIEWS (2002)
Furin at the cutting edge: From protein traffic to embryogenesis and disease
G Thomas
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Regulation of cell survival by secreted proneurotrophins
R Lee et al.
SCIENCE (2001)
Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses
M Hatta et al.
SCIENCE (2001)
Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells
DE Bassi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The pathogenesis of influenza in humans
MC Zambon
REVIEWS IN MEDICAL VIROLOGY (2001)
Polyarginines are potent furin inhibitors
A Cameron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A protein-based therapeutic for human cytomegalovirus infection
F Jean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
